BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August

Day

• 2
• 3
• 4
• 5
• 6
• 7
• 9
• 10
• 11
• 12
• 13
• 14
• 16
• 17
• 18
• 19
• 20
• 21
• 23
• 24
• 25

• Press Releases

  Sensorium Therapeutics Announces SNTX-2643 Phase 1a Data to Be Presented at Psych Congress 2026

  August 19, 2026

   · 

  3 min read
• Press Releases

  Arcato Announces Phase 1 Clinical Trial Results and Closing of Fully Subscribed Financing Round

  August 19, 2026

   · 

  2 min read
• Press Releases

  SandboxAQ Launches AQPotency, Bringing Ultrafast Virtual Screening to Drug Discovery Without a Solved Protein Structure

  August 19, 2026

   · 

  4 min read
• Press Releases

  Zipalertinib Plus Chemotherapy First-Line Phase 3 REZILIENT3 Trial Data Selected for Presidential Symposium Presentation at the IASLC 2026 World Conference on Lung Cancer

  August 19, 2026

   · 

  7 min read
• Press Releases

  Marvel Biosciences Expands Private Placement to Quebec

  August 19, 2026

   · 

  5 min read
• Press Releases

  Pasatru™ (garetosmab-grts) First and Only FDA-approved Treatment Demonstrating Reduction in New Heterotopic Ossification (HO) Lesions and Clinician-Assessed Flare-ups in a Placebo-controlled Trial in Adults with Fibrodysplasia Ossificans Progressiva (FOP)

  August 19, 2026

   · 

  16 min read
• 

  FDA

  Trump’s FDA pick Overton good for psychedelics, new pain meds but bad for vaccines: Analysts

  If confirmed by the Senate, Heidi Overton—officially revealed Wednesday as President Donald Trump’s choice for FDA commissioner—is expected to be a boon for developers of psychedelic therapeutics and non-opioid pain drugs, but could tow the party line on vaccines.

  August 19, 2026

   · 

  3 min read

   · 

  Heather McKenzie
• Press Releases

  Revive Therapeutics Announces Proposed Shares for Debt Settlement

  August 19, 2026

   · 

  1 min read
• Press Releases

  OSR Health Receives Nasdaq Staff Delisting Determination and Intends to Request Hearings Panel Appeal

  August 19, 2026

   · 

  4 min read
• Press Releases

  Amplitude Therapeutics and Lilly Enter Strategic Collaboration to Develop Trans-Amplifying RNA Vaccines for Infectious Diseases

  August 19, 2026

   · 

  2 min read